John Oliver Thomas Given
Oprichter bij Brandon Point Industries Ltd.
Oorsprong van het eerstegraads netwerk van John Oliver Thomas Given
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 14 | |
Serenus Biotherapeutics, Inc.
Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA.
9
| Subsidiary | Medical Distributors | 9 |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland.
4
| Private Company | Medical/Nursing Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Oliver Thomas Given via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IMMUCOR, INC. | Medical Specialties | Director/Board Member | |
XOMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Bain Capital Public Equity LP
Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity LP is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1996 as Brookside Capital LP. They are wholly-owned by Bain Capital LP, itself a subsidiary of Bain Capital Holdings LP. Bain Capital Public Equity provides investment advisory services to pooled investment vehicles (Public Equity Funds). Investors in the Public Equity Funds includes high net-worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities. | Investment Managers | Analyst-Equity | |
TELKOM SA SOC LTD | Major Telecommunications | Director/Board Member | |
Brookside Capital Investors LP | Director/Board Member | ||
RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chairman | |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Executive Officer | |
NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree | |
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Financial Conglomerates | Director/Board Member | |
Brookside Capital, Inc.
Brookside Capital, Inc. Investment ManagersFinance Brookside Capital, Inc. is an independent wealth management firm headquartered in San Francisco, California. The firm was founded by James Rea in 1989. They provide investment management services to high-net worth individuals and charitable organizations. | Investment Managers | Director/Board Member | |
Ziff Brothers Investments LLC
Ziff Brothers Investments LLC Investment ManagersFinance Founded in 1992, Ziff Brothers Investments LLC is a hedge fund manager located in New York City. The firm is the primary investment vehicle of the Ziff family, founders of Ziff-Davis Publishing. | Investment Managers | Corporate Officer/Principal | |
Western Illinois University | College/University | Undergraduate Degree | |
University College Dublin | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cipla Medpro South Africa (Pty) Ltd.
Cipla Medpro South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Cipla Medpro South Africa Ltd. engages in the business of manufacturing, marketing and supply of pharmaceutical products. It provides medicines and products for the cure of diseases such as cardio-respiratory, diabetes, oncology, neuro-psychiatry and human immunodeficiency virus and acquired immune deficiency syndrome. The company was founded in 2003 and is headquartered in Cape Town, South Africa. | Pharmaceuticals: Major | Chairman | |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | Investment Managers | Portfolio Manager-Equities | |
Telkom Media Pty Ltd.
Telkom Media Pty Ltd. Cable/Satellite TVConsumer Services Part of Shenzhen Media Group, Telkom Media Pty Ltd. provides commercial satellite and cable subscription broadcasting services. The company is based in Pretoria, South Africa. Telkom Media was acquired by Shenzhen Media Group from Telkom SA SOC Ltd. on May 06, 2009. | Cable/Satellite TV | Director/Board Member | |
Ithala Development Finance Corp. Ltd.
Ithala Development Finance Corp. Ltd. Financial ConglomeratesFinance Ithala Development Finance Corp. Ltd. is a private company based in KwaZulu-Natal, South Africa, with subsidiaries in the country. The South African company's Business Finance Unit aims to empower local businesses and promote job creation in the province by offering a range of products and services, including finance and skills development. Ithala also manages a portfolio of properties available for lease, including large and light industrial spaces, retail properties, and SMME spaces. The company is committed to investing in corporate social investment to create sustainable economic growth and uplift historically disadvantaged communities. The CEO of the company is Yvonne Zwane. | Financial Conglomerates | Chief Executive Officer | |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Chairman Director/Board Member | |
Chartered Accountants Ireland | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Xenex Disinfection Services, Inc.
Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | Medical Specialties | Director/Board Member | |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Pharmaceuticals: Major | Director/Board Member | |
POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Olivo Laboratories LLC
Olivo Laboratories LLC Medical/Nursing ServicesHealth Services Olivo Laboratories LLC provides solutions to skin-related medical problems through proprietary biomaterials technologies. Its platform technology consists of a tunable polysiloxane-based material that mimics youthful skin and can be engineered to provide a variety of targeted properties, including elasticity, breathability, invisibility, water resistance, protection. The company was founded by Robert S. Langer Jr. and Richard Rox Anderson and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
IKENA ONCOLOGY, INC. | Biotechnology | Chairman | |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
NeuVt Ltd.
NeuVt Ltd. MiscellaneousMiscellaneous NeuVt Ltd. is a private company headquartered in Dublin, Ireland. The firm functions as an investment holding company. | Miscellaneous | Director/Board Member | |
University of Illinois At Urbana–Champaign | College/University | Graduate Degree | |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Xenex Corp. | Director/Board Member | ||
Sail Bio, Inc. | Chief Executive Officer | ||
TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO |
Statistieken
Internationaal
Verenigde Staten | 38 |
Ierland | 7 |
Zuid-Afrika | 5 |
Verenigd Koninkrijk | 4 |
Sectoraal
Health Technology | 26 |
Finance | 13 |
Consumer Services | 7 |
Communications | 2 |
Health Services | 2 |
Operationeel
Director/Board Member | 133 |
Chairman | 46 |
Independent Dir/Board Member | 42 |
Corporate Officer/Principal | 32 |
Chief Executive Officer | 32 |
Sterkste connecties
Insiders | |
---|---|
Robert Alexander Ingram | 43 |
Owen Hughes | 23 |
Sean Murphy | 22 |
George Martin | 21 |
Penuell Luthuli | 20 |
Nigel Ten Fleming | 19 |
Menghisteab Bairu | 15 |
Adrian Howd | 14 |
John Herlihy | 11 |
Uwe Bicker | 11 |
Kieran McGowan | 11 |
William Daniel | 10 |
Kyran McLaughlin | 6 |
Darragh Lyons | 5 |
Fiona Dunlevy | 4 |
- Beurs
- Insiders
- John Oliver Thomas Given
- Bedrijfsconnecties